EN
Dexcom Continuous Glucose Monitoring (CGM)
The Future of Diabetes Management is here.
Putting the power of continuous glucose readings in the hands of patients and their healthcare teams – which helps improve diabetes management, increase treatment satisfaction, and improve quality of life.
About Dexcom G6
Smart devices not included
Patient
Outcomes
With Dexcom CGM
Reduces A1C, regardless of insulin delivery method1,2
Increases time in range1,3,4
Reduces time in hypoglycemia1,3,5
Reduces fear of hypoglycemia3 and improves hypoglycemia confidence6
Reduces hypoglycemic events5,6,7
A closer look at the components
Dexcom G6 CGM System
Sensor
Inserted just underneath the skin with a simple one-touch applicator, the sensor measures interstitial glucose levels.
Transmitter
The transmitter sends data wirelessly to a display device.
Display Device
An Apple or Android compatible smart device§ or touch screen receiver displays real-time glucose data, and allows patient data uploads to Dexcom CLARITY¶.
Smart device not included
“Dexcom G6 is technology that empowers people with diabetes. As a Paediatric Endocrinologist, I know the fear parents have of unrecognized hypoglycemia. This technology makes me a better doctor by providing the information needed to fine tune insulin therapy to meet the needs of my patients.”
Dr. Angelo Simone | Pediatric Endocrinologist
Dr. Simone is a spokesperson of Dexcom Canada, Co.
Dexcom technology
Dexcom CLARITY
With Dexcom CLARITY software, you can have ongoing visibility into your patients’ data.
This will enable you and your team to evaluate patients' glucose patterns, analyze data
and diabetes management plans – all from your clinic computer.
- • Invite patients to share their data for quick access and efficient visits
- • Access all your patients’ data in one easy-to-use clinic portal with 8 interactive reports
Prescribe Now
Access the latest information, tools and resources that will enable you to start prescribing
Dexcom CGM to your patients today.
Prescribe Now
Dexcom Resources
Clinical Evidence
Review evidence demonstrating the impact continuous glucose monitoring (CGM) use can have
on glycemic control and quality of life.
Clinic Resources
Find prescribing information, and documentation on clinic site training for CGM.
Webinars
New to continuous glucose monitoring? Experienced? Attend an educational event, or series of events.
No webinars are currently scheduled. Return to this space soon to check for regular updates.
§ For a list of compatible devices, please visit dexcom.com/compatibility. Use of the smart watch requires the Dexcom G6 App on a compatible smartphone.
¶ An internet connection is required to send data to Dexcom CLARITY.
1 Beck RW, et al. JAMA 2017;317:371-8.
2 Beck RW, et al. Lancet Diabetes Endocrinol 2017;5:700-8.
3 Reddy M, et at. Diabet Med 2018;35:483-90.
4 Reddy M, et al. Diabetes Technol Ther 2018;20 :751-57.
5 Heinemann L, et al. Lancet 2018;391 :1367-77.
6 Ólafsdóttir AF, et al. Diabetes Technol Ther 2018; 20 :274 – 84.
7 Riddlesworth T, et al. Diabetes Ther 2017;8 :947-51.
¶ An internet connection is required to send data to Dexcom CLARITY.
1 Beck RW, et al. JAMA 2017;317:371-8.
2 Beck RW, et al. Lancet Diabetes Endocrinol 2017;5:700-8.
3 Reddy M, et at. Diabet Med 2018;35:483-90.
4 Reddy M, et al. Diabetes Technol Ther 2018;20 :751-57.
5 Heinemann L, et al. Lancet 2018;391 :1367-77.
6 Ólafsdóttir AF, et al. Diabetes Technol Ther 2018; 20 :274 – 84.
7 Riddlesworth T, et al. Diabetes Ther 2017;8 :947-51.
© 2020 Dexcom Canada, Co. All rights reserved.
This product is covered by U.S. patent.
LBL020208 Rev001
This product is covered by U.S. patent.
LBL020208 Rev001
Safety Information ·
Privacy Policy ·
Terms of Use ·
Site Map
© 2020 Dexcom, Dexcom G6, Dexcom G5 Mobile, Dexcom G4, Dexcom Follow and Dexcom CLARITY, Dexcom Share, Share are registered trademarks of Dexcom, Co. in the U.S., and may be registered in other countries.
© 2020 Dexcom, Dexcom G6, Dexcom G5 Mobile, Dexcom G4, Dexcom Follow and Dexcom CLARITY, Dexcom Share, Share are registered trademarks of Dexcom, Co. in the U.S., and may be registered in other countries.